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Background: Micronutrient supplementation has been extensively explored as a strategy to improve
health and reduce risk of chronic diseases. Fat-soluble vitamins like A and E with their antioxidant
properties and mechanistic interactions with lipoproteins, have potentially a key impact on lipid
metabolism and lipidemia.
Objective: The impact of micronutrients on lipid metabolism requires further investigation including
characterization of plasma lipidome following supplementation and any cause-effect on circulating
lipids.
Design: In this study, we elucidate the effect and associations of a multi-micronutrient intervention in
Brazilian children and teens with lipoprotein alterations and lipid metabolism.
Results: Our analysis suggests a combination of short and long-term impact of supplementation on lipid
metabolism, potentially mediated primarily by a-tocopherol (vitamin E) and retinol (vitamin A). Among
the lipid classes, levels of phospholipids, lysophospholipids, and cholesterol esters were impacted the
most along with differential incorporation of stearic, palmitic, oleic and arachidonic acids. Integrated
analysis with proteomic data suggested potential links to supplementation-mediated alterations in
protein levels of phospholipases and pyruvate dehydrogenase kinase 1 (PDK1).
Conclusions: Associations between the observed differences in lipidemia, total triglyceride, and VLDL-
cholesterol levels suggest that micronutrients may play a role in reducing these risk factors for cardio-
vascular disease in children. This would require further investigation.
© 2019 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Micronutrients have critical functions in fetal programming [1]
through aging [2]. Deﬁciencies in micronutrient status can severely
impact growth and development [3], skeletal and extra skeletal
processes [4], and cardiovascular health [5,6]. Supplementation of
diet with one or combinations of vitamins and minerals have been
explored with the aim of reducing chronic diseases [7e12], usually
in adults. Speciﬁcally, the impact on cardiovascular health ofry, Inselspital, Bern University
d.
oodi).
r Ltd. This is an open access article
, Impact of multi-micronutrie
.09.010micronutrients, particularly vitamins A, C and E [5,13e16], has
recently been reviewed [17]. Vitamin E has also been used to treat
nonalcoholic steatohepatitis in children [18] and nonalcoholic fatty
liver disease in children and adolescents [19].
Fat-soluble vitamins, such as vitamin A precursors and
vitamin E, act as free radical scavengers and are part of the
antioxidant defense system [20] which also includes Cu, Zn and
Mn. Deﬁciencies in any of these components decreases antioxi-
dant protection. After absorption in the intestines, vitamin E and
A are packaged into the chylomicrons on route to be incorporated
into very low density lipoproteins (VLDL). Changes in lipid
metabolism may alter any process dependent on these vitamins.
Several other vitamins also play key mechanistic roles in lipid
metabolism [21] speciﬁcally vitamin A [22,23], B12 [24], B6 [25],under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
nt supplementation on lipidemia of children and adolescents, Clinical
Abbreviation list
PDK1 Pyruvate Dehydrogenase Kinase 1
VLDL very low density lipoproteins
IDL intermediate density lipoproteins
LDL low density lipoproteins
HDL high density lipoproteins
CE cholesteryl ester
SE sterol ester
DAG diacylglycerol
TAG triacylglycerol
Cer ceramide
SM sphingomyelin
LPC lysophosphatidylcholine
LPE lysophosphatidylethanolamine
LPI lysophosphatidylinositol
LPS lysophosphatidylserine
LPG lysophosphatidylglycerol
LPA lysophosphatidic acid
PC phosphatidylcholine
PE phosphatidylethanolamine
PI phosphatidylinositol
PS phosphatidylserine
PG phosphatidylglycerol
PA phosphatidic acid
FDR false discovery rate
LDL-c LDL-cholesterol
V1 Visit 1
V2 Visit 2
V3 Visit 3
PLA2G2A phospholipase A2 group IIA
PLA2G10 phospholipase A2 group 10
PLA2G5 phospholipase A2 group V
PLA2G1B phospholipase A2 group 1B
PLA2G2E phospholipase A2 group 2E
A. Chakrabarti et al. / Clinical Nutrition xxx (xxxx) xxx2and D [26]. Potential associations between multi-micronutrient
uptake and lipid proﬁles have also been conducted in children
[27] and adults [28]. However, these studies analyzed changes in
HDL, LDL, VLDL levels but not speciﬁc lipid species which limits
mechanistic insights into changes in lipid metabolism. In this
study, we investigated the effects and associations of a multi-
micronutrient intervention with lipoproteins alterations.
Plasma lipidome and proteome were analyzed in samples from a
6-week multivitamin/mineral intervention [29] in 9e13 year olds
in Brazil.
2. Materials and methods
2.1. Clinical trial
The clinical trial including the study design has previously
been described in detail by Mathias et al. [29]. Brieﬂy, healthy
children and adolescents (aged between 9 and 13 years, 11 months
and 29 days) from three schools in the west side of Ribeir~ao Preto
(Administrative district 2), Brazil, were provided micronutrients
(Nestrovit™) that included vitamin A, vitamin E, folate, vitamin
B1, vitamin B2, niacin, vitamin B6, vitamin B12, vitamin D3,
vitamin C, biotin, vitamin B5 and calcium, phosphorus, iron,
magnesium and zinc for 5 days a week for 6 weeks (March to June,
2013 and 2014) in each of 2 successive years. Summary of the dose
of each supplemented micronutrient is provided in
Supplementary Table 1. The dose of 2 bars for ages 9e11 and 3 for
ages 11 þ corresponded to approximately 100% daily recom-
mended allowances but less than upper tolerable level for most
nutrients (supplementary table and Mathias et al. [29]). Six of the
authors from the Mathias et al. [29] study individually monitored
supplement intake at the beginning of each school period to
ensure the supplement was taken by the individual. The adher-
ence rate was 98% over both years. We report data
(Supplementary Data 1) from the ﬁrst year of the study, which
included a six week intervention period followed by a six week
washout period. Visit 1 (V1) is deﬁned as the visit before the start
of the intervention period. Visit 2 (V2) is deﬁned as the visit upon
completion of the six week intervention period and visit 3 (V3) is
deﬁned as the visit upon completion of the six week washout
period. Assessments at each visit included anthropometrics, blood
biochemistry, vitamins, lipidomics, proteomics and dietary habits.
Dietary habits were also assessed (details in Mathias et al. [29]).
141 children and adolescents were enrolled in baseline with 135Please cite this article as: Chakrabarti A et al., Impact of multi-micronutrie
Nutrition, https://doi.org/10.1016/j.clnu.2019.09.010participants completing the six week intervention and subsequent
six week washout part of the study. Table summarizing the de-
mographic information and general health information of the
participants is provided in Supplementary Table 2. Energy, car-
bohydrate, lipid, ﬁber and protein intake assessments of the par-
ticipants is provided in Supplementary Data 2 following the
methods described in Mathias et al. [29]. The trial was registered
on ClinTrials.gov (NCT01823744).
2.2. Lipidomics analysis
We conducted comprehensive lipidomics analysis on fasted
(12 h) plasma samples. Lipid extraction and analysis were per-
formed as reported previously [30]. In summary, plasma was
diluted 50 fold with 150 mM ammonium bicarbonate aqueous
solution. 180 mL diluted plasma was pipetted in a polypropylene
deep well plate and 810 mL methyl tert-butyl ether/methanol (7:2,
v/v) containing internal standards was added to extract lipids. The
internal standard mixture contained cholesterol-d6, cholesteryl
ester (CE) 20:0, diacylglycerol (DAG) 17:0/17:0, triacylglycerol (TAG)
17:0/17:0/17:0, ceramide (Cer) 18:1;2/17:0, sphingomyelin (SM)
18:1;2/12:0, lysophosphatidylcholine (LPC) 12:0, lysophosphati-
dylethanolamine (LPE) 17:1, lysophosphatidylinositol (LPI) 13:0,
lysophosphatidylserine (LPS) 13:0, lysophosphatidylglycerol (LPG)
17:1, lysophosphatidic acid (LPA) 17:0, phosphatidylcholine (PC)
17:0/17:0, phosphatidylethanolamine (PE) 17:0/17:0, phosphatidy-
linositol (PI) 16:0/16:0, phosphatidylserine (PS) 17:0/17:0, phos-
phatidylglycerol (PG) 17:0/17:0, and phosphatidic acid (PA) 17:0/
17:0. The plate was shaken for 15 min at 4 C and centrifuged for
5 min at 300 g to separate phases. 100 mL of the organic phase was
transferred to a 96-well plate and dried under vacuum. Lipid
extract was reconstituted in 40 mL of 7.5 mM ammonium acetate in
chloroform/methanol/propanol (1:2:4, V/V/V) and immediately
analyzed.
Samples were analyzed by direct infusion in a QExactive mass
spectrometer (Thermo Fisher Scientiﬁc) equipped with a TriVersa
NanoMate ion source (Advion Biosciences). In brief, 5 mL of extract
was infused during 5 min and analyzed in both polarities in a single
acquisition. Cholesterol, CE, DAG, and TAG were monitored in FTMS
positive mode while phospholipids were monitored in negative
mode. For each polarities, MS full scans (Rm/z ¼ 200 ¼ 140 000)
were followed by a MS/MS data-independent analysis over a
similar mass range with a resolving power of 17 500 (atm/z ¼ 200)
and an isolation width of 1.0 Da.nt supplementation on lipidemia of children and adolescents, Clinical
A. Chakrabarti et al. / Clinical Nutrition xxx (xxxx) xxx 3All data was analyzed with in-house developed lipid identiﬁ-
cation software based on LipidXplorer. Data post-processing and
normalization were performed on an in-house developed R based
package.
2.3. Assessment of plasma 25-Hydroxy Vitamin D3 levels
25-Hydroxy Vitamin D3 levels were measured using published
methods [31] at Vitas® (Oslo, Norway).
2.4. Proteomics analysis
For protein measurement, samples were analyzed using DNA-
aptamer based recognition on the SOMAscan platform (Soma-
Logic, Boulder, CO, USA), as described by Gold et al. [32]. Median
normalized relative ﬂuorescence units (RFUs) were log2-
transformed before applying principal component analysis and
linear models [33]. Statistical analyses were performed in R 3.1.3 (R
Foundation for Statistical Computing).
2.5. Baseline data processing
Of the 141 (V1) children and adolescents enrolled in the study,
136 participants completed all the assessments (i.e. participation
and analysis in V2 and V3). Outliers in these participants were
identiﬁed using principal component analysis for clinical and
vitamin parameters separately and for each time point (as
described earlier in Mathias et al. [29]). Outliers were deﬁned as
samples falling outside of the 99% conﬁdence ellipse at any time
point. Six individuals were identiﬁed as statistical outliers for
clinical variables (namely Fat freemass (% of body weight), Fat mass
(% of body weight), Glucose (mg/dL), Total Cholesterol (mg/dL), LDL
Cholesterol (mg/dL), HDL Cholesterol (mg/dL), Triglycerides (mg/
dL), Mean corpuscular volume (ﬂ), Mean corpuscular hemoglobin
(pg), Basophils (% of total white blood cells), Platelets (number of
cells x 103/ul), Albumin (g/dL), Calcium (mmol/L), Iron (mg/dL) and
Phosphate (mg/dL)). Six individuals were statistical outliers for
circulating vitamin levels. These individuals were excluded from
further analyses, thus leaving 123 participants for the lipidomics
analysis. Additionally, we used the lipid measurements as a ﬁnal
ﬁltering criterion. If any lipid species contained greater than 25
percent of missing values for any visit, they were not considered for
further analysis. If greater than 25 percent of lipid measurements
were not available for any individual, they were not considered for
further analysis. Considering this work to be an extension to the
Mathias et al. [29] study, where the exclusion criterion for vitamin
and clinical variables were set to be 25% of missing values the same
cut-off was used to avoid type II errors (false negatives) due to an
insufﬁcient sample size (n) and to be consistent with the previous
analysis. Accordingly, four individuals were removed for further
analysis. Ultimately, we retained 119 individuals for the analysis
presented in this study.
2.6. Statistical and correlation analysis
The statistical comparisons were made between two visits (i.e.
between V1eV2, V1eV3, V2eV3) individually. We used the Wil-
coxon signed rank test, which is a nonparametric test for paired
observations, for between visit comparisons. P-values were cor-
rected for multiple testing calculating the false discovery rate (FDR)
adjusted p-values using the BenjaminieHochberg procedure [34]
and the signiﬁcance threshold was set to 0.05.
To assess the correlations between the different measurements,
we used Spearmans Rank correlation. The P-values were similarly
corrected for multiple testing calculating the false discovery ratePlease cite this article as: Chakrabarti A et al., Impact of multi-micronutrie
Nutrition, https://doi.org/10.1016/j.clnu.2019.09.010(FDR) adjusted p-values using the BenjaminieHochberg procedure
[34] and the signiﬁcance threshold was set to 0.05.
2.7. Ethics
The trial was registered on ClinTrials.gov (NCT01823744).
Enrolled participants signed the statement of informed assent and a
parent of each participant signed informed consent. Participants
received Institutional Review Board (Brazilian National Ethics
Committee, CONEP 00969412.6.0000.5440) approved compensa-
tion as well as breakfast and lunch following blood draws on each
asses visit.
3. Results
3.1. Clinical study
The primary ﬁndings of the clinical trial including the study
design has previously been described in detail byMathias et al. [29]
and Toffano et al. [35]. Brieﬂy, the multi-micronutrients used in the
study signiﬁcantly and reproducibly impacted the levels of total
cholesterol, LDL-cholesterol (LDL-c), glucose and nine circulating
organic vitamin forms (including FMN, nudiﬂoramide, pantothenic
acid, pyridoxal, a-tocopherol, 5-methyltetrahydrofolic acid, folate,
vitamin B12 and g-tocopherol). The intervention did not signiﬁ-
cantly impact the plasma levels of circulating 25-Hydroxy Vitamin
D3 levels (details inmaterials andmethods), with themedian levels
of 57 nmol/L for V1, 65 nmol/L for V2 and 52 nmol/L for V3 (indi-
vidual participant measurements are provided in Supplementary
Table 3 and Supplementary Data 3. The decrease of average levels
of blood lipids and glucose suggested that one or a combination of
vitamins and minerals in the supplement inﬂuenced lipid meta-
bolism, similar to ﬁndings in earlier studies [26,36e46]. We
extended these ﬁndings to how the intervention affected lipid
metabolism.
3.2. Lipidomics assessment
We conducted untargeted lipidomics of intact lipid species and
identiﬁed DAGs (diacylglycerols), SEs (sterol esters), TAGs (tri-
acylglycerols), free cholesterol, LPCs (lysophosphatidylcholines),
LPAs (lysophosphatidic acids), LPEs (lysophosphatidylethanol-
amines), PIs (phosphatidylinositols), PCs (phosphatidylcholines)
among others. After processing and cleaning detailed in materials
and methods, all species reliably detected across different visits
were used in this analysis. Subsequently, we also ﬁltered lipids
within each visit, based on 25 percent of missing measurements.
Accordingly, some lipid species such as SE 20:0, TAG 48:3, TAG 54:2,
PI 34:1, PE 38:4, PC 37:3, PC 40:4 were excluded from further
analysis. In terms of the participants, we retained 119 participants
for ﬁnal lipidomic analysis (details in materials and methods).
Ten SEs, 7 TAGs, free cholesterol, 7 LPCs, 3 PI and 15 PCs were
signiﬁcantly different between at least one inter-visit comparison
(Fig. 1). Overall, we observed statistically signiﬁcant reduction in
lipid levels upon intervention and also during washout. Fifteen
lipids were reduced signiﬁcantly between V1 and V2, suggesting a
direct and rapid impact of intervention. These included 6 SEs, 3 PIs,
2 PCs, 2 LPCs, free cholesterol, and 1 LPE (Fig. 1). SEs levels were
reduced themost (7.49e12.67% based onmean fold changes, Fig. 1).
Seventeen different lipids were statistically changed between
V2 and V3 including 3which also reduced between V1eV2 (SE 18:1,
SE 20:3 and PC 36:2). These included 4 SEs, 7 TAGs and 6 PCs. The
magnitude of reduction was 10.18e15.59% in SE levels,
12.51e21.25% in TAG levels and 8.18e14.69% in PC levels. Similarly,
a slower but long-term impact of intervention and/or a new steadynt supplementation on lipidemia of children and adolescents, Clinical
Fig. 1. Changes in lipid levels measured across visits. Increase or decrease in lipid
levels in cross-visit comparisons are indicated by blue (decrease) or green (increase)
ﬁlled boxes. Mean fold changes of lipids across visits are indicated by the numbers in
the boxes. (For interpretation of the references to color in this ﬁgure legend, the reader
is referred to the Web version of this article.)
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Nutrition, https://doi.org/10.1016/j.clnu.2019.09.010state between V1 and V3, was found with 40 signiﬁcantly different
lipids, including 10 which were different between V2eV3 and 15
lipids which differed between V1eV2. These included 10 SEs,
15 PCs, 7 LPCs, free cholesterol, 4 LPE and 3 PIs. The magnitude of
reduction was 13.59e31.38% in SE levels, 9e23.21% in PC levels,
4.62e12% in LPC levels. All analyzed PCs, LPCs, and SEs had reduced
levels between V1 and V2 and their levels were further reduced
between V2eV3, indicating a potential long-term impact of the
intervention. For example, the level of SE 20:3 was 12.68% lower at
V2 compared to V1 and 25.29% reduced between V1 and V3. In
comparison, free cholesterol levels were 12.25% lower between
V1eV2 but 11.82% between V1eV3.
3.3. Relationship of lipid species to other parameters
The intervention led to reduction of the LDL-cholesterol levels
measured through standard clinical chemistry methods [29]. While
the intervention did not impact HDL-cholesterol, VLDL-cholesterol
and triglycerides levels (deﬁned by no statistically differences be-
tween V1 and V2), we observed that total cholesterol levels and
total free cholesterol were lower after the intervention along when
measured by untargeted lipidomics. To understand the relation-
ships between lipoproteins and the speciﬁc lipid species, we
analyzed the correlations between the changes in different lipid
species in VLDL, LDL and HDL at each of the visits. Changes of levels
of triglyceride and VLDL cholesterol levels at different visits were
similarly correlated to changes in DAGs, TAGs, which reduced
signiﬁcantly during the washout phase (Fig. 2). Changes in
composition of DAGs and TAGs are consistent with the changes in
lipoprotein particles reported previously [47]: VLDL was enriched
in TAGs, HDL had higher levels of phospholipids. HDL-cholesterol
measurements were negatively correlated to the DAGs only dur-
ing washout phase. LDL-cholesterol and total cholesterol were
similarly correlated to SE 18:2 (Fig. 2) at visit 3.
We also investigated the correlations between the changes in
lipids and circulating organic vitamin forms. Following the inter-
vention, a-tocopherol was highly correlated to several PCs, PIs,
TAGs, SEs and DAGs (Fig. 3). a-tocopherol and retinol were similarly
correlated to several SEs when comparing V1 to V3, while the
positive correlations between a-tocopherol and PIs and PCs
remained. During the washout phase (V2eV3), a-tocopherol and
retinol were strongly positively correlated to several lipids across
different classes, including free cholesterol levels. g-Tocopherol was
positively correlated to PC 36:2, PC 34:2 and PI 36:2 during the
intervention phase and several TAGs, DAG 36:4 and PC 34:3 during
washout phase. a-b carotene was positively correlated to LPC 14:0
and SE 17:0 during the washout phase. 5-methyltetrahydrofolic
acid was positively correlated to PC 38:4 during the intervention
phase and with SE 17:0 during the washout phase (Fig. 3).
Overall, correlation analysis highlights the potential key role of
fat soluble vitamins (e.g. A, E) more than the water soluble vitamins
(e.g. B, C) and its potential interactions with the different lipids
classes, speciﬁcally SEs, PCs, TAGs, DAGs and PIs. Fatty acid
composition analysis of the differentially observed lipid species
suggested that intervention led to reduction in incorporation of
linoleic acid (C 18:2), palmitic acid (C 16:0), oleic acid (C 18:1),
arachidonic acid (C 20:4), stearic acid (C 18:0), palmitoleic acid (C
16:1) (Fig. 4), in the decreasing order of number of species
impacted.
3.4. Plasma proteomics analysis
Plasma proteins were analyzed in each participant at each visit
using aptamer-based detection [32]. In general, the differentially
observed proteins highlighted alterations in the host immunent supplementation on lipidemia of children and adolescents, Clinical
Fig. 2. Correlations of changes in measured lipid species (deltas between the visits) against changes in cholesterol measurements.
A. Chakrabarti et al. / Clinical Nutrition xxx (xxxx) xxx 5system, cytokine signaling, altered protein and lipid metabolism.
We speciﬁcally focused on the potential connections to lipid
metabolism. In that regard, we identiﬁed approximately 30 pro-
teins, which were speciﬁcally impacted by the intervention
(marked by statistically different levels between V1 and V2, P
values after FDR correction < 0.05). These proteins were implicated
in impacting phospholipid metabolism, glycerophospholipid
metabolism, sphingolipid de novo biosynthesis and metabolism,
synthesis of PA/PC and acyl chain remodeling of PI/PG/PS/PC/PE
using the Reactome database [48]. Phospholipases (PLA2G2A,
PLA2G10, PLA2G5), which mediate hydrolysis of phospholipids to
fatty acids, were changed by the intervention. For example,
PLA2G2A (phospholipase A2 group IIA) levels increased following
the supplementation (p ¼ 0.0108). In contrast, PLA2G10 (phos-
pholipase A2 group 10 - p ¼ 0.00004) and PLA2G5 (phospholipase
A2 group V - p ¼ 0.0058) levels decreased after the supplementa-
tion (p ¼ 0.00004). PLA2G2A levels were not statistically differentPlease cite this article as: Chakrabarti A et al., Impact of multi-micronutrie
Nutrition, https://doi.org/10.1016/j.clnu.2019.09.010after the washout as compared to the baseline, indicating that
vitamin supplements are needed for the effect. However, PLA2G10
(p ¼ 2.06e-08) and PLA2G5 (p ¼ 0.0002) levels were signiﬁcantly
lower after washout (V1eV3), indicating a long-term impact of
supplementation. Long term (i.e. changes between V1 and V3 and
not between V1 and V2) also altered the levels of phospholipases
like PLA2G1B (phospholipase A2 group 1B, V3>V1, p ¼ 0.0279) and
PLA2G2E (phospholipase A2 group 2E, V1>V3, p ¼ 0.0166). These
changesmay be directly due to the supplementation as described in
earlier studies [48]. Additionally, we observed a decrease in PDK1
(pyruvate dehydrogenase kinase 1) levels upon supplementation
(V1>V2, p ¼ 0.0024) which recovered during washout (V3>V2,
p ¼ 0.0023). PDK1 plays a key role in regulating the formation of
acetyl-coenzyme A from pyruvate. Potentially, these alterations in
the protein levels could be a reason to alter the in-ﬂow of fatty acids
and potential alterations to the pool of different lipids (as demar-
cated in Fig. 4).nt supplementation on lipidemia of children and adolescents, Clinical
Fig. 3. Correlations of changes in measured lipid species (deltas between the visits) against changes in circulating vitamin forms.
A. Chakrabarti et al. / Clinical Nutrition xxx (xxxx) xxx64. Discussion
Micronutrients play a signiﬁcant role in health and disease
[1e16] with effects on clinical measures of plasma lipid levels
[20e28]. However, changes in lipid species due to vitamin sup-
plementation has not been well described. We focused onPlease cite this article as: Chakrabarti A et al., Impact of multi-micronutrie
Nutrition, https://doi.org/10.1016/j.clnu.2019.09.010evaluating the impact of multi-micronutrient supplementation
(vitamin A, vitamin E, folate, vitamin B1, vitamin B2, niacin, vitamin
B6, vitamin B12, vitamin D3, vitamin C, biotin, vitamin B5 and
calcium, phosphorus, iron, magnesium and zinc) to the circulating
lipoprotein levels and lipidemia, thus highlighting the in-depth
impact of micronutrient intervention on lipid metabolism andnt supplementation on lipidemia of children and adolescents, Clinical
Fig. 4. Schematic overview of the observed alterations in lipids upon supplementation.
A. Chakrabarti et al. / Clinical Nutrition xxx (xxxx) xxx 7hypothesizing potential underlying mechanisms for these obser-
vations. The primary ﬁndings of the clinical study were previously
presented by Mathias et al. [29].
Vitamin supplementation led to statistically signiﬁcant re-
ductions in the levels of several lipid classes, including SEs, PIs, PCs
and LPCs (Fig. 1). Impact on some of the lipid species occurred only
after the intervention (i.e. changed only between V1eV2), sug-
gesting the presence of additional vitamins and minerals were
required to maintain the lipid levels (e.g., free cholesterol). How-
ever, some lipid levels changed both between V1eV2 and during
washout (V2eV3) in the same direction, indicating a potential long-
term impact. In other cases, the levels of some lipid species were
maintained throughout the washout period (V1eV3) or in other
cases, between V2 and V3. Thus, supplementation had short-term
and long-term impacts on selected lipid species. In the current
study, we are limited to a 6-week window for both supplementa-
tion and washout. A longer chronic cross-over study would further
elucidate the plasticity of the impacts on lipidemia.
Analysis of the lipid species suggested that supplementation led
to reduction of species with at least one linoleic, oleic, palmitic,
stearic and arachidonic acid in the side chains. For example, we
found that linoleic acid in the form of PC, SE and TAGs, oleic acid in
the form of TAGs, SE and PC, palmitic acid in the form of PC, SE, LPC,
arachidonic acid in the form of SE, PI and PC and stearic acid in the
form of PI, PC and LPC (both in short and long term) reduced upon
supplementation. We also observed reduction in TAGs and SEs
enriched in palmitic acid, which is considered to have a positive
impact on metabolic health [50,51]. Our ﬁndings also agree with
our previous observation that cholesteryl linoleate (SE 18:2) is the
most abundant lipid species in LDL particles [47]. Elevated LDL-
cholesterol and elevated TAGs amongst others are key for cardio-
vascular risk prediction and management. In that regard, micro-
nutrient based reduction in LDL-cholesterol potentially mediated
by the reduction in SEs could be vital in the cardiovascular risks in
adulthood. Taken together, these results demonstrate that supple-
mentation had a strong inﬂuence in determining the lipid proﬁlePlease cite this article as: Chakrabarti A et al., Impact of multi-micronutrie
Nutrition, https://doi.org/10.1016/j.clnu.2019.09.010and impacting the metabolism of some speciﬁc fatty acids namely
linoleic, palmitic, oleic and stearic acids.
Changes in several lipid species (speciﬁcally DAGs, TAGs and
PCs) were consistently positively correlated to changes in compo-
sition of speciﬁc lipids in triglyceride and VLDL cholesterol (Fig. 2).
These results are relevant to reducing metabolic/cardiovascular
risks. Additionally, changes in PCs, PIs, TAGs, SEs and DAGs were
strongly correlated to the plasma levels of fat-soluble vitamin E (a-
tocopherol). We previously reported that supplementation led to
statistically signiﬁcant increase in a-tocopherol levels, which
reduced to below baseline levels uponwashout (Mathias et al. [29]).
The correlations between a-tocopherol and TAGs became even
more pronounced during the washout phase. Vitamin A (retinol),
which did not change signiﬁcantly during supplementation but
reduced during washout, was strongly correlated to several lipid
classes including SEs, TAGs, LPCs, LPEs, PIs and PCs. A vitamin A
deﬁcient diet has a prooxidative effect and inﬂuences cellular and
molecular regulation of phospholipid metabolism and function
[52]. Deﬁciency of vitamin A has been shown to decrease liver
phospholipid content in rats [53] and has been attributed to lower
synthesis of phosphatidylcholine and lower availability of fatty
acids [54], decrease of linoleic acid and a high level of saturated
long-chain fatty acids, 16:0 and 18:0, in the heart mitochondrial
phospholipids [55]. Mechanistically, vitamin E impacts phospholi-
pase activity and directly impacts phospholipid metabolism [49].
One report found that hydrolysis of acyl groups of PC was inhibited
by increasing dietary vitamin E [49]. Our observations of reduced
levels of C16:0, C18:0 components in lipids and the correlations
between the lipids and the vitamins (A and E) are consistent with
these studies mentioned above.
To further explore the potential connections between vitamins
supplementation and the lipids, we used proteomic analysis to
characterize the plasma protein levels. Phospholipases A1 and A2
are the major enzymes responsible for generation of LPC from PC.
Increase in vitamin E supplementation has been shown earlier to
reduce phospholipases A1 and A2 activity [49]. We observed annt supplementation on lipidemia of children and adolescents, Clinical
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PLA2G2A protein levels increased and PLA2G10 and PLA2G5 levels
decreased. Additionally, pyruvate kinase activity (indicator of
myopathy) is reported to be reduced upon increase in vitamin E
feeding [49]. Consistent with this, we noticed that the micro-
nutrient supplementation led to reduction in the protein levels
of PDK1.
Our analysis suggests that multi-micronutrient supplementa-
tion has a combination of a short-term and long-term impact on
lipid metabolism with a signiﬁcant impact on the circulating levels
of phospholipids, lysophospholipids and cholesterol esters (Fig. 4).
Combining these observations with the changes in observed pro-
tein levels of phospholipases and PDK1, we suggest a potential
mechanism explaining these observations (Fig. 4). The levels of
phospholipids changed and the incorporation of different fatty
acids such as stearic, palmitic, oleic and arachidonic acids was also
altered following the intervention. Correlation based analysis
highlighted the potential importance of a-tocopherol (vitamin E)
and retinol (vitamin A) in comparison to the other components in
the supplement. Finally, the associations between the observed
changes in lipid species and VLDL-cholesterol levels further eluci-
dated the impact of micronutrient intervention on lipid meta-
bolism. The changes in levels of these lipid species suggest that
micronutrients may play a role in reducing the risk of cardiovas-
cular diseases. However, this conclusion requires further investi-
gation. While we assume that our study population is healthy
(based on the exclusion criterion described in Mathias et al. [29]),
we cannot control the presence of any unknown condition or dis-
ease that could inﬂuence the metabolism [56,57].
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